Vascular endothelial growth factor receptor 2 (VEGFR2) participates in the mediation of atherosclerosis, the main underlying pathophysiological basis of CAD, by promoting angiogenesis and inflammation. The gene discussed is KDR; the disease is coronary artery disorder.